2nd EFMC² Tandem Talks

Confirmed Speakers


Confirmed Speakers

BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe
Dr Léa BOUCHÉ (ROCHE, Basel, Switzerland)
Read more
Dr Judith GÜNTHER (BAYER PHARMA AG, Berlin, Germany)
Read more

Sponsored by

Copyright 2024 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys